This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-126-5p | ABCA12 | 0.22 | 0.0501 | -1.3 | 1.0E-5 | mirMAP | -0.27 | 0.01666 | NA | |
2 | hsa-miR-126-5p | ABCB5 | 0.22 | 0.0501 | 0.03 | 0.9111 | mirMAP | -0.19 | 0.0485 | NA | |
3 | hsa-miR-130b-5p | ABCC3 | 1.15 | 0 | -1.19 | 0 | mirMAP | -0.43 | 0 | NA | |
4 | hsa-miR-126-5p | ABCC9 | 0.22 | 0.0501 | -1.23 | 0 | mirMAP | -0.14 | 0.04239 | NA | |
5 | hsa-miR-126-5p | ABLIM1 | 0.22 | 0.0501 | -0.73 | 0 | mirMAP | -0.14 | 0.00596 | NA | |
6 | hsa-miR-126-5p | ACOT11 | 0.22 | 0.0501 | -1.43 | 0 | mirMAP | -0.26 | 0.00012 | NA | |
7 | hsa-miR-130b-5p | ACPP | 1.15 | 0 | 0.1 | 0.70864 | mirMAP | -0.18 | 0.01854 | NA | |
8 | hsa-miR-130b-5p | ACSL4 | 1.15 | 0 | -1.19 | 0 | MirTarget | -0.33 | 0 | NA | |
9 | hsa-miR-130b-5p | ADAM22 | 1.15 | 0 | -1.06 | 1.0E-5 | MirTarget | -0.36 | 0 | NA | |
10 | hsa-miR-130b-5p | ADAM23 | 1.15 | 0 | -1.03 | 0 | mirMAP | -0.35 | 0 | NA | |
11 | hsa-miR-130b-5p | ADAMTS12 | 1.15 | 0 | -0.6 | 0.00161 | mirMAP | -0.21 | 6.0E-5 | NA | |
12 | hsa-miR-130b-5p | ADAMTS5 | 1.15 | 0 | -1.91 | 0 | miRNATAP | -0.43 | 0 | NA | |
13 | hsa-miR-130b-5p | ADD2 | 1.15 | 0 | 0.23 | 0.38613 | mirMAP | -0.31 | 4.0E-5 | NA | |
14 | hsa-miR-130b-5p | ADD3 | 1.15 | 0 | -0.99 | 0 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
15 | hsa-miR-130b-5p | AFAP1 | 1.15 | 0 | -0.34 | 4.0E-5 | mirMAP | -0.1 | 0 | NA | |
16 | hsa-miR-126-5p | AFF2 | 0.22 | 0.0501 | -1.9 | 0 | mirMAP; miRNATAP | -0.19 | 0.02483 | NA | |
17 | hsa-miR-130b-5p | AFF2 | 1.15 | 0 | -1.9 | 0 | mirMAP | -0.47 | 0 | NA | |
18 | hsa-miR-126-5p | AGPAT4 | 0.22 | 0.0501 | -0.67 | 0 | mirMAP | -0.15 | 0.00525 | NA | |
19 | hsa-miR-130b-5p | AGPAT4 | 1.15 | 0 | -0.67 | 0 | mirMAP | -0.34 | 0 | NA | |
20 | hsa-miR-126-5p | AGPS | 0.22 | 0.0501 | -0.88 | 0 | mirMAP | -0.12 | 0.00851 | NA | |
21 | hsa-miR-126-5p | AJAP1 | 0.22 | 0.0501 | -1.01 | 0 | mirMAP | -0.19 | 0.02137 | NA | |
22 | hsa-miR-130b-5p | AKAP2 | 1.15 | 0 | -1.25 | 3.0E-5 | mirMAP | -0.33 | 7.0E-5 | NA | |
23 | hsa-miR-130b-5p | AKAP6 | 1.15 | 0 | -0.91 | 0 | MirTarget | -0.26 | 0 | NA | |
24 | hsa-miR-130b-5p | ALDH1B1 | 1.15 | 0 | -0.33 | 7.0E-5 | miRNAWalker2 validate | -0.15 | 0 | NA | |
25 | hsa-miR-126-5p | ANGPTL1 | 0.22 | 0.0501 | -1.94 | 0 | mirMAP | -0.19 | 0.04016 | NA | |
26 | hsa-miR-126-5p | ANKDD1A | 0.22 | 0.0501 | -0.62 | 0 | mirMAP | -0.13 | 0.00215 | NA | |
27 | hsa-miR-126-5p | ANKRD45 | 0.22 | 0.0501 | -1.55 | 0 | mirMAP | -0.18 | 0.02109 | NA | |
28 | hsa-miR-130b-5p | ANKRD50 | 1.15 | 0 | 0.05 | 0.63242 | miRNATAP | -0.14 | 0 | NA | |
29 | hsa-miR-130b-5p | ANO5 | 1.15 | 0 | -1.93 | 0 | MirTarget | -0.67 | 0 | NA | |
30 | hsa-miR-126-5p | ANP32E | 0.22 | 0.0501 | -1.17 | 0 | mirMAP | -0.12 | 0.00914 | NA | |
31 | hsa-miR-126-5p | ANTXR2 | 0.22 | 0.0501 | -0.69 | 0 | MirTarget | -0.13 | 0.0064 | NA | |
32 | hsa-miR-130b-5p | ANTXR2 | 1.15 | 0 | -0.69 | 0 | mirMAP; miRNATAP | -0.17 | 0 | NA | |
33 | hsa-miR-126-5p | APLF | 0.22 | 0.0501 | -0.91 | 0 | mirMAP | -0.17 | 0.00035 | NA | |
34 | hsa-miR-126-5p | ARHGAP20 | 0.22 | 0.0501 | -1.96 | 0 | mirMAP | -0.2 | 0.00836 | NA | |
35 | hsa-miR-130b-5p | ARHGAP31 | 1.15 | 0 | -0.55 | 0 | mirMAP | -0.16 | 0 | NA | |
36 | hsa-miR-130b-5p | ARL10 | 1.15 | 0 | -1.23 | 0 | mirMAP | -0.31 | 0 | NA | |
37 | hsa-miR-126-5p | ARL4C | 0.22 | 0.0501 | -0.78 | 0 | MirTarget; mirMAP; miRNATAP | -0.15 | 0.00141 | NA | |
38 | hsa-miR-130b-5p | ARL4C | 1.15 | 0 | -0.78 | 0 | mirMAP; miRNATAP | -0.29 | 0 | NA | |
39 | hsa-miR-126-5p | ARL6IP6 | 0.22 | 0.0501 | -0.24 | 0.00097 | mirMAP | -0.11 | 5.0E-5 | NA | |
40 | hsa-miR-126-5p | ARRDC3 | 0.22 | 0.0501 | -0.49 | 2.0E-5 | mirMAP | -0.16 | 0.00013 | NA | |
41 | hsa-miR-130b-5p | ARRDC3 | 1.15 | 0 | -0.49 | 2.0E-5 | miRNATAP | -0.26 | 0 | NA | |
42 | hsa-miR-126-5p | ARSJ | 0.22 | 0.0501 | -1.03 | 0 | mirMAP | -0.3 | 0 | NA | |
43 | hsa-miR-130b-5p | ASPH | 1.15 | 0 | -1.11 | 0 | MirTarget | -0.2 | 0 | NA | |
44 | hsa-miR-130b-5p | ASTN1 | 1.15 | 0 | -2.02 | 0 | MirTarget | -0.4 | 0 | NA | |
45 | hsa-miR-126-5p | ATCAY | 0.22 | 0.0501 | -1.63 | 0 | mirMAP | -0.39 | 4.0E-5 | NA | |
46 | hsa-miR-130b-5p | ATCAY | 1.15 | 0 | -1.63 | 0 | mirMAP | -0.65 | 0 | NA | |
47 | hsa-miR-130b-5p | ATP10D | 1.15 | 0 | -0.76 | 0 | mirMAP | -0.25 | 0 | NA | |
48 | hsa-miR-126-5p | ATP1B1 | 0.22 | 0.0501 | -1.17 | 0 | mirMAP | -0.19 | 0.00037 | NA | |
49 | hsa-miR-130b-5p | ATXN1 | 1.15 | 0 | -0.46 | 2.0E-5 | mirMAP | -0.18 | 0 | NA | |
50 | hsa-miR-130b-5p | AVPR2 | 1.15 | 0 | -0.24 | 0.12825 | mirMAP | -0.11 | 0.014 | NA | |
51 | hsa-miR-126-5p | B4GALT6 | 0.22 | 0.0501 | -0.82 | 0 | mirMAP | -0.16 | 0.00016 | NA | |
52 | hsa-miR-130b-5p | B4GALT6 | 1.15 | 0 | -0.82 | 0 | MirTarget | -0.2 | 0 | NA | |
53 | hsa-miR-130b-5p | BACH2 | 1.15 | 0 | -0.74 | 0 | mirMAP | -0.23 | 0 | NA | |
54 | hsa-miR-126-5p | BCL11A | 0.22 | 0.0501 | -1.44 | 0 | mirMAP | -0.38 | 2.0E-5 | NA | |
55 | hsa-miR-126-5p | BCL2 | 0.22 | 0.0501 | -1.2 | 0 | mirMAP | -0.2 | 0.00033 | NA | |
56 | hsa-miR-130b-5p | BCL2 | 1.15 | 0 | -1.2 | 0 | mirMAP | -0.29 | 0 | 27364335 | The level of microRNA-130b in relationship with the expression of PPARĪ³ VEGF-A BCL-2 and apoptosis were analyzed in 91 lung cancer patient samples using immunohistochemistry and terminal deoxynucleotidyl transferase dUTP nick end labeling TUNEL assay on tissue microarrays; In vitro and in vivo miR-130b enrichment associated with down-regulation of PPARĪ³ up-regulation of VEGF-A and BCL-2 and decreased apoptosis |
57 | hsa-miR-130b-5p | BCL6 | 1.15 | 0 | -0.36 | 0.00062 | MirTarget; miRNATAP | -0.11 | 0.00012 | NA | |
58 | hsa-miR-126-5p | BDH2 | 0.22 | 0.0501 | -1.01 | 0 | MirTarget | -0.13 | 0.01144 | NA | |
59 | hsa-miR-130b-5p | BDKRB2 | 1.15 | 0 | -1.01 | 0 | mirMAP | -0.35 | 0 | NA | |
60 | hsa-miR-126-5p | BEND6 | 0.22 | 0.0501 | -0.83 | 0 | mirMAP | -0.16 | 0.0018 | NA | |
61 | hsa-miR-126-5p | BHLHE41 | 0.22 | 0.0501 | -0.25 | 0.10102 | mirMAP | -0.14 | 0.01183 | NA | |
62 | hsa-miR-130b-5p | BMP7 | 1.15 | 0 | -1.55 | 0 | mirMAP | -0.62 | 0 | NA | |
63 | hsa-miR-126-5p | BNC2 | 0.22 | 0.0501 | -1.29 | 0 | mirMAP | -0.16 | 0.01014 | NA | |
64 | hsa-miR-130b-5p | BNC2 | 1.15 | 0 | -1.29 | 0 | miRNATAP | -0.45 | 0 | NA | |
65 | hsa-miR-126-5p | BVES | 0.22 | 0.0501 | -1.18 | 0 | mirMAP | -0.24 | 0.00055 | NA | |
66 | hsa-miR-126-5p | C11orf45 | 0.22 | 0.0501 | -1.74 | 0 | miRNATAP | -0.21 | 0.00181 | NA | |
67 | hsa-miR-130b-5p | C17orf51 | 1.15 | 0 | -0.61 | 0 | mirMAP | -0.15 | 0 | NA | |
68 | hsa-miR-126-5p | C1D | 0.22 | 0.0501 | -0.11 | 0.12 | mirMAP | -0.16 | 0 | NA | |
69 | hsa-miR-130b-5p | C1QTNF2 | 1.15 | 0 | -0.59 | 0.00025 | mirMAP | -0.24 | 0 | NA | |
70 | hsa-miR-126-5p | C1RL | 0.22 | 0.0501 | -0.17 | 0.13006 | MirTarget | -0.17 | 4.0E-5 | NA | |
71 | hsa-miR-130b-5p | C1orf204 | 1.15 | 0 | -0.88 | 0 | miRNATAP | -0.31 | 0 | NA | |
72 | hsa-miR-130b-5p | C20orf194 | 1.15 | 0 | -1.17 | 0 | mirMAP | -0.31 | 0 | NA | |
73 | hsa-miR-126-5p | C2orf88 | 0.22 | 0.0501 | -2.69 | 0 | mirMAP | -0.33 | 0.00015 | NA | |
74 | hsa-miR-126-5p | C3orf58 | 0.22 | 0.0501 | -0.39 | 6.0E-5 | mirMAP | -0.11 | 0.00392 | NA | |
75 | hsa-miR-126-5p | C3orf70 | 0.22 | 0.0501 | -1.44 | 0 | mirMAP | -0.25 | 9.0E-5 | NA | |
76 | hsa-miR-126-5p | C9orf47 | 0.22 | 0.0501 | -0.53 | 0.00074 | mirMAP | -0.19 | 0.0012 | NA | |
77 | hsa-miR-126-5p | CACNB4 | 0.22 | 0.0501 | -0.97 | 0 | mirMAP | -0.26 | 4.0E-5 | NA | |
78 | hsa-miR-126-5p | CALD1 | 0.22 | 0.0501 | -1.23 | 0 | mirMAP | -0.18 | 0.00025 | NA | |
79 | hsa-miR-130b-5p | CAMK1D | 1.15 | 0 | -1.36 | 0 | mirMAP | -0.36 | 0 | NA | |
80 | hsa-miR-130b-5p | CAMK2A | 1.15 | 0 | -1.67 | 0 | mirMAP | -0.34 | 0 | NA | |
81 | hsa-miR-130b-5p | CAMK4 | 1.15 | 0 | -1.01 | 0 | mirMAP | -0.37 | 0 | NA | |
82 | hsa-miR-130b-5p | CBX6 | 1.15 | 0 | -0.85 | 0 | mirMAP | -0.17 | 2.0E-5 | NA | |
83 | hsa-miR-130b-5p | CCND2 | 1.15 | 0 | -1.36 | 0 | mirMAP | -0.36 | 0 | NA | |
84 | hsa-miR-130b-5p | CCNJL | 1.15 | 0 | -1.46 | 0 | mirMAP | -0.42 | 0 | NA | |
85 | hsa-miR-130b-5p | CD93 | 1.15 | 0 | -0.21 | 0.09856 | mirMAP | -0.14 | 0.00011 | NA | |
86 | hsa-miR-130b-5p | CD99L2 | 1.15 | 0 | -0.42 | 0 | mirMAP | -0.1 | 0 | NA | |
87 | hsa-miR-126-5p | CDCA7 | 0.22 | 0.0501 | -0.62 | 0.00061 | MirTarget; miRNATAP | -0.32 | 0 | NA | |
88 | hsa-miR-130b-5p | CDCA7L | 1.15 | 0 | -0.54 | 0.0004 | MirTarget | -0.2 | 0 | NA | |
89 | hsa-miR-130b-5p | CDH19 | 1.15 | 0 | -1.61 | 0 | MirTarget | -0.52 | 0 | NA | |
90 | hsa-miR-130b-5p | CDH23 | 1.15 | 0 | -1.61 | 0 | mirMAP | -0.41 | 0 | NA | |
91 | hsa-miR-130b-5p | CEACAM1 | 1.15 | 0 | -0.52 | 0.00737 | mirMAP | -0.41 | 0 | NA | |
92 | hsa-miR-126-5p | CELF2 | 0.22 | 0.0501 | -1.12 | 0 | mirMAP; miRNATAP | -0.13 | 0.0247 | NA | |
93 | hsa-miR-130b-5p | CERK | 1.15 | 0 | -1.2 | 0 | mirMAP | -0.25 | 0 | NA | |
94 | hsa-miR-126-5p | CFL2 | 0.22 | 0.0501 | -1.33 | 0 | MirTarget; mirMAP | -0.14 | 0.00243 | NA | |
95 | hsa-miR-130b-5p | CGNL1 | 1.15 | 0 | -0.15 | 0.12316 | miRNAWalker2 validate; MirTarget | -0.1 | 0.00014 | NA | |
96 | hsa-miR-130b-5p | CHD1 | 1.15 | 0 | -0.2 | 0.07933 | miRNAWalker2 validate | -0.15 | 0 | NA | |
97 | hsa-miR-126-5p | CHL1 | 0.22 | 0.0501 | -0.41 | 0.12478 | mirMAP | -0.22 | 0.03355 | NA | |
98 | hsa-miR-126-5p | CHODL | 0.22 | 0.0501 | -0.6 | 0.01606 | mirMAP | -0.36 | 0.00013 | NA | |
99 | hsa-miR-126-5p | CHRDL1 | 0.22 | 0.0501 | -2.13 | 0 | mirMAP | -0.31 | 0.00049 | NA | |
100 | hsa-miR-130b-5p | CHRDL1 | 1.15 | 0 | -2.13 | 0 | MirTarget; miRNATAP | -0.67 | 0 | NA | |
101 | hsa-miR-130b-5p | CHST3 | 1.15 | 0 | -1.2 | 0 | mirMAP | -0.36 | 0 | NA | |
102 | hsa-miR-130b-5p | CLIP3 | 1.15 | 0 | -1.43 | 0 | miRNATAP | -0.41 | 0 | NA | |
103 | hsa-miR-126-5p | CLIP4 | 0.22 | 0.0501 | -1.23 | 0 | mirMAP | -0.22 | 2.0E-5 | NA | |
104 | hsa-miR-130b-5p | CLVS2 | 1.15 | 0 | -2.48 | 0 | MirTarget | -0.73 | 0 | NA | |
105 | hsa-miR-126-5p | CNTN1 | 0.22 | 0.0501 | -1.78 | 0 | MirTarget | -0.22 | 0.04692 | NA | |
106 | hsa-miR-126-5p | CNTNAP3 | 0.22 | 0.0501 | -0.45 | 0.01716 | mirMAP | -0.16 | 0.02394 | NA | |
107 | hsa-miR-130b-5p | COL27A1 | 1.15 | 0 | -1.35 | 0 | mirMAP | -0.47 | 0 | NA | |
108 | hsa-miR-130b-5p | CPXM2 | 1.15 | 0 | -0.05 | 0.77971 | mirMAP | -0.21 | 1.0E-5 | NA | |
109 | hsa-miR-126-5p | CRYZ | 0.22 | 0.0501 | -0.84 | 0 | mirMAP | -0.13 | 0.00014 | NA | |
110 | hsa-miR-130b-5p | CSRP1 | 1.15 | 0 | -1.5 | 0 | mirMAP | -0.41 | 0 | NA | |
111 | hsa-miR-130b-5p | CYBB | 1.15 | 0 | -0.14 | 0.39968 | mirMAP | -0.17 | 0.00025 | NA | |
112 | hsa-miR-130b-5p | CYBRD1 | 1.15 | 0 | -0.65 | 0 | mirMAP | -0.29 | 0 | NA | |
113 | hsa-miR-126-5p | CYP24A1 | 0.22 | 0.0501 | -1.49 | 0.00015 | mirMAP | -0.46 | 0.00209 | NA | |
114 | hsa-miR-130b-5p | CYP26B1 | 1.15 | 0 | -1.24 | 0 | mirMAP | -0.26 | 2.0E-5 | NA | |
115 | hsa-miR-130b-5p | CYYR1 | 1.15 | 0 | -0.69 | 0 | MirTarget | -0.16 | 0 | NA | |
116 | hsa-miR-126-5p | DAB1 | 0.22 | 0.0501 | -2.75 | 0 | mirMAP | -0.43 | 0.0004 | NA | |
117 | hsa-miR-126-5p | DACH2 | 0.22 | 0.0501 | -1.01 | 0.0039 | mirMAP | -0.31 | 0.01929 | NA | |
118 | hsa-miR-126-5p | DCBLD2 | 0.22 | 0.0501 | -0.76 | 0 | mirMAP | -0.13 | 0.00027 | NA | |
119 | hsa-miR-126-5p | DCDC2 | 0.22 | 0.0501 | -0.24 | 0.3307 | MirTarget; mirMAP; miRNATAP | -0.19 | 0.04947 | NA | |
120 | hsa-miR-130b-5p | DENND5B | 1.15 | 0 | -0.49 | 3.0E-5 | MirTarget | -0.13 | 4.0E-5 | NA | |
121 | hsa-miR-130b-5p | DIO2 | 1.15 | 0 | 0.21 | 0.177 | miRNATAP | -0.18 | 2.0E-5 | NA | |
122 | hsa-miR-130b-5p | DIO3 | 1.15 | 0 | -0.63 | 0.00012 | mirMAP | -0.3 | 0 | NA | |
123 | hsa-miR-126-5p | DMD | 0.22 | 0.0501 | -1.67 | 0 | MirTarget; mirMAP | -0.16 | 0.02432 | NA | |
124 | hsa-miR-130b-5p | DNAH3 | 1.15 | 0 | -0.11 | 0.69134 | mirMAP | -0.18 | 0.02072 | NA | |
125 | hsa-miR-126-5p | DNAJB4 | 0.22 | 0.0501 | -1.41 | 0 | mirMAP | -0.16 | 0.00576 | NA | |
126 | hsa-miR-130b-5p | DRP2 | 1.15 | 0 | -0.6 | 0.00037 | mirMAP | -0.34 | 0 | NA | |
127 | hsa-miR-126-5p | DSG3 | 0.22 | 0.0501 | -1.91 | 0 | mirMAP | -0.4 | 0.00329 | NA | |
128 | hsa-miR-130b-5p | DST | 1.15 | 0 | -1.08 | 0 | mirMAP | -0.34 | 0 | NA | |
129 | hsa-miR-130b-5p | DTX4 | 1.15 | 0 | -0.48 | 1.0E-5 | mirMAP | -0.19 | 0 | NA | |
130 | hsa-miR-126-5p | DUSP19 | 0.22 | 0.0501 | -1.15 | 0 | mirMAP | -0.16 | 7.0E-5 | NA | |
131 | hsa-miR-130b-5p | DUSP3 | 1.15 | 0 | -0.71 | 0 | MirTarget | -0.15 | 0 | NA | |
132 | hsa-miR-130b-5p | EBF4 | 1.15 | 0 | -0.47 | 0.00012 | miRNATAP | -0.22 | 0 | NA | |
133 | hsa-miR-126-5p | EDA2R | 0.22 | 0.0501 | -1.15 | 0 | MirTarget | -0.17 | 0.00739 | NA | |
134 | hsa-miR-126-5p | EDAR | 0.22 | 0.0501 | -2.05 | 0 | mirMAP | -0.56 | 0 | NA | |
135 | hsa-miR-130b-5p | EDAR | 1.15 | 0 | -2.05 | 0 | mirMAP | -0.55 | 0 | NA | |
136 | hsa-miR-130b-5p | EDN3 | 1.15 | 0 | -2.3 | 0 | mirMAP | -0.69 | 0 | NA | |
137 | hsa-miR-126-5p | EDNRA | 0.22 | 0.0501 | -1.35 | 0 | mirMAP | -0.24 | 0.00011 | NA | |
138 | hsa-miR-130b-5p | EFNB1 | 1.15 | 0 | -1.33 | 0 | mirMAP; miRNATAP | -0.26 | 0 | NA | |
139 | hsa-miR-130b-5p | EGR3 | 1.15 | 0 | -0.38 | 0.14781 | mirMAP | -0.32 | 1.0E-5 | NA | |
140 | hsa-miR-130b-5p | EHD3 | 1.15 | 0 | -0.26 | 0.00997 | mirMAP | -0.12 | 1.0E-5 | NA | |
141 | hsa-miR-130b-5p | ELF3 | 1.15 | 0 | 0.05 | 0.76137 | mirMAP | -0.19 | 1.0E-5 | NA | |
142 | hsa-miR-126-5p | EPHA3 | 0.22 | 0.0501 | -0.73 | 8.0E-5 | mirMAP | -0.15 | 0.03152 | NA | |
143 | hsa-miR-126-5p | EPHA5 | 0.22 | 0.0501 | -1.46 | 1.0E-5 | mirMAP | -0.32 | 0.00776 | NA | |
144 | hsa-miR-126-5p | EPHA7 | 0.22 | 0.0501 | -0.61 | 0.00129 | mirMAP; miRNATAP | -0.3 | 2.0E-5 | NA | |
145 | hsa-miR-130b-5p | EPHA7 | 1.15 | 0 | -0.61 | 0.00129 | miRNATAP | -0.31 | 0 | NA | |
146 | hsa-miR-126-5p | EPHB1 | 0.22 | 0.0501 | -2.38 | 0 | MirTarget | -0.2 | 0.03078 | NA | |
147 | hsa-miR-126-5p | ERAP1 | 0.22 | 0.0501 | -0.61 | 0 | mirMAP | -0.11 | 0.00385 | NA | |
148 | hsa-miR-130b-5p | ERBB4 | 1.15 | 0 | -1.22 | 0 | miRNATAP | -0.21 | 0.00058 | NA | |
149 | hsa-miR-130b-5p | ERC1 | 1.15 | 0 | -0.63 | 0 | mirMAP | -0.12 | 0 | NA | |
150 | hsa-miR-130b-5p | ESR1 | 1.15 | 0 | -0.31 | 0.08775 | mirMAP | -0.33 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL DEVELOPMENT | 89 | 1426 | 3.498e-15 | 1.628e-11 |
2 | MORPHOGENESIS OF AN EPITHELIUM | 41 | 400 | 4.785e-14 | 1.113e-10 |
3 | NEURON PROJECTION DEVELOPMENT | 48 | 545 | 1.003e-13 | 1.545e-10 |
4 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 26 | 167 | 1.66e-13 | 1.545e-10 |
5 | TISSUE DEVELOPMENT | 89 | 1518 | 1.336e-13 | 1.545e-10 |
6 | GLAND MORPHOGENESIS | 20 | 97 | 4.772e-13 | 3.701e-10 |
7 | TISSUE MORPHOGENESIS | 46 | 533 | 6.96e-13 | 4.626e-10 |
8 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 91 | 1672 | 4.601e-12 | 2.676e-09 |
9 | NEURON DEVELOPMENT | 51 | 687 | 1.117e-11 | 4.727e-09 |
10 | EPITHELIUM DEVELOPMENT | 62 | 945 | 1.158e-11 | 4.727e-09 |
11 | NEUROGENESIS | 80 | 1402 | 1.128e-11 | 4.727e-09 |
12 | NEURON DIFFERENTIATION | 59 | 874 | 1.219e-11 | 4.727e-09 |
13 | NEURON PROJECTION GUIDANCE | 26 | 205 | 2.062e-11 | 7.382e-09 |
14 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 35 | 368 | 3.038e-11 | 1.01e-08 |
15 | REGULATION OF CELL DIFFERENTIATION | 82 | 1492 | 3.964e-11 | 1.153e-08 |
16 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 42 | 513 | 3.954e-11 | 1.153e-08 |
17 | CELL PROJECTION ORGANIZATION | 59 | 902 | 4.327e-11 | 1.184e-08 |
18 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 54 | 788 | 5.58e-11 | 1.333e-08 |
19 | CIRCULATORY SYSTEM DEVELOPMENT | 54 | 788 | 5.58e-11 | 1.333e-08 |
20 | BIOLOGICAL ADHESION | 64 | 1032 | 5.731e-11 | 1.333e-08 |
21 | NEURON PROJECTION MORPHOGENESIS | 36 | 402 | 8.711e-11 | 1.93e-08 |
22 | TUBE DEVELOPMENT | 43 | 552 | 1.125e-10 | 2.379e-08 |
23 | VASCULATURE DEVELOPMENT | 39 | 469 | 1.283e-10 | 2.595e-08 |
24 | DEVELOPMENTAL GROWTH | 32 | 333 | 1.673e-10 | 3.244e-08 |
25 | ORGAN MORPHOGENESIS | 54 | 841 | 6.058e-10 | 1.084e-07 |
26 | GROWTH | 35 | 410 | 5.855e-10 | 1.084e-07 |
27 | GLAND DEVELOPMENT | 34 | 395 | 8.364e-10 | 1.441e-07 |
28 | CELLULAR COMPONENT MORPHOGENESIS | 56 | 900 | 9.045e-10 | 1.503e-07 |
29 | TUBE MORPHOGENESIS | 30 | 323 | 1.422e-09 | 2.282e-07 |
30 | BLOOD VESSEL MORPHOGENESIS | 32 | 364 | 1.579e-09 | 2.385e-07 |
31 | ORGAN GROWTH | 14 | 68 | 1.589e-09 | 2.385e-07 |
32 | STEM CELL DIFFERENTIATION | 22 | 190 | 4.164e-09 | 6.055e-07 |
33 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 63 | 1142 | 8.454e-09 | 1.192e-06 |
34 | MESENCHYMAL CELL DIFFERENTIATION | 18 | 134 | 1.04e-08 | 1.423e-06 |
35 | TAXIS | 35 | 464 | 1.468e-08 | 1.952e-06 |
36 | MESENCHYME DEVELOPMENT | 21 | 190 | 2.15e-08 | 2.778e-06 |
37 | LOCOMOTION | 60 | 1114 | 4.675e-08 | 5.879e-06 |
38 | CELL PART MORPHOGENESIS | 41 | 633 | 6.26e-08 | 7.665e-06 |
39 | POSITIVE REGULATION OF CELL PROLIFERATION | 48 | 814 | 8.151e-08 | 9.725e-06 |
40 | POSITIVE REGULATION OF GENE EXPRESSION | 81 | 1733 | 9.011e-08 | 1.048e-05 |
41 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 53 | 957 | 1.266e-07 | 1.435e-05 |
42 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 45 | 750 | 1.295e-07 | 1.435e-05 |
43 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 82 | 1805 | 2.461e-07 | 2.664e-05 |
44 | UROGENITAL SYSTEM DEVELOPMENT | 25 | 299 | 2.591e-07 | 2.708e-05 |
45 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 16 | 131 | 2.619e-07 | 2.708e-05 |
46 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 14 | 104 | 4.399e-07 | 4.449e-05 |
47 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 63 | 1275 | 4.556e-07 | 4.51e-05 |
48 | CELL CELL ADHESION | 38 | 608 | 4.717e-07 | 4.573e-05 |
49 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 54 | 1036 | 6.492e-07 | 6.041e-05 |
50 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 54 | 1036 | 6.492e-07 | 6.041e-05 |
51 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 44 | 771 | 7.095e-07 | 6.473e-05 |
52 | REGULATION OF CELL PROLIFERATION | 70 | 1496 | 7.403e-07 | 6.624e-05 |
53 | MUSCLE TISSUE DEVELOPMENT | 23 | 275 | 7.767e-07 | 6.819e-05 |
54 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 53 | 1021 | 9.402e-07 | 8.101e-05 |
55 | SALIVARY GLAND DEVELOPMENT | 8 | 32 | 1.101e-06 | 9.148e-05 |
56 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 66 | 1395 | 1.092e-06 | 9.148e-05 |
57 | MORPHOGENESIS OF AN EPITHELIAL FOLD | 6 | 15 | 1.15e-06 | 9.388e-05 |
58 | PROSTATE GLAND MORPHOGENESIS | 7 | 23 | 1.219e-06 | 9.781e-05 |
59 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 23 | 285 | 1.441e-06 | 0.0001117 |
60 | POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 10 | 56 | 1.419e-06 | 0.0001117 |
61 | HEART DEVELOPMENT | 31 | 466 | 1.518e-06 | 0.0001158 |
62 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 41 | 724 | 2.09e-06 | 0.0001568 |
63 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 56 | 1135 | 2.199e-06 | 0.0001624 |
64 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 13 | 103 | 2.382e-06 | 0.0001732 |
65 | BRANCH ELONGATION OF AN EPITHELIUM | 6 | 17 | 2.722e-06 | 0.0001948 |
66 | MUSCLE STRUCTURE DEVELOPMENT | 29 | 432 | 2.77e-06 | 0.0001953 |
67 | KIDNEY EPITHELIUM DEVELOPMENT | 14 | 125 | 4.142e-06 | 0.0002876 |
68 | MUSCLE SYSTEM PROCESS | 22 | 282 | 4.227e-06 | 0.0002892 |
69 | POSITIVE REGULATION OF MAPK CASCADE | 30 | 470 | 5.126e-06 | 0.0003457 |
70 | REGULATION OF CELL DEVELOPMENT | 44 | 836 | 5.858e-06 | 0.0003894 |
71 | REGULATION OF PROTEIN MODIFICATION PROCESS | 74 | 1710 | 6.095e-06 | 0.0003994 |
72 | EPIDERMIS MORPHOGENESIS | 7 | 29 | 6.79e-06 | 0.0004328 |
73 | POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 7 | 29 | 6.79e-06 | 0.0004328 |
74 | REGULATION OF CELL ADHESION | 36 | 629 | 7.035e-06 | 0.0004423 |
75 | MESONEPHRIC TUBULE MORPHOGENESIS | 9 | 53 | 7.39e-06 | 0.0004524 |
76 | HEAD DEVELOPMENT | 39 | 709 | 7.373e-06 | 0.0004524 |
77 | REGULATION OF NEURON DIFFERENTIATION | 33 | 554 | 7.505e-06 | 0.0004535 |
78 | APPENDAGE DEVELOPMENT | 16 | 169 | 7.858e-06 | 0.000457 |
79 | LIMB DEVELOPMENT | 16 | 169 | 7.858e-06 | 0.000457 |
80 | ANGIOGENESIS | 22 | 293 | 7.803e-06 | 0.000457 |
81 | PROSTATE GLAND DEVELOPMENT | 8 | 41 | 8.161e-06 | 0.0004607 |
82 | NEPHRON DEVELOPMENT | 13 | 115 | 8.218e-06 | 0.0004607 |
83 | LUNG ALVEOLUS DEVELOPMENT | 8 | 41 | 8.161e-06 | 0.0004607 |
84 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 43 | 823 | 8.983e-06 | 0.0004976 |
85 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 14 | 135 | 1.02e-05 | 0.0005584 |
86 | RESPONSE TO WOUNDING | 33 | 563 | 1.047e-05 | 0.0005664 |
87 | RESPIRATORY SYSTEM DEVELOPMENT | 17 | 197 | 1.414e-05 | 0.0007564 |
88 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 14 | 140 | 1.55e-05 | 0.0008193 |
89 | RESPONSE TO EXTERNAL STIMULUS | 76 | 1821 | 1.614e-05 | 0.0008437 |
90 | LUNG MORPHOGENESIS | 8 | 45 | 1.682e-05 | 0.0008509 |
91 | EXOCRINE SYSTEM DEVELOPMENT | 8 | 45 | 1.682e-05 | 0.0008509 |
92 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 44 | 872 | 1.665e-05 | 0.0008509 |
93 | REGULATION OF ORGAN MORPHOGENESIS | 19 | 242 | 1.732e-05 | 0.0008664 |
94 | MESONEPHROS DEVELOPMENT | 11 | 90 | 1.934e-05 | 0.0009571 |
95 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 34 | 609 | 2.116e-05 | 0.001024 |
96 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 69 | 1618 | 2.105e-05 | 0.001024 |
97 | NEURAL CREST CELL DIFFERENTIATION | 10 | 75 | 2.136e-05 | 0.001024 |
98 | REGULATION OF CELL PROJECTION ORGANIZATION | 32 | 558 | 2.195e-05 | 0.001042 |
99 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 26 | 408 | 2.24e-05 | 0.001053 |
100 | POSITIVE REGULATION OF CELL COMMUNICATION | 66 | 1532 | 2.371e-05 | 0.001103 |
101 | NEPHRON EPITHELIUM DEVELOPMENT | 11 | 93 | 2.644e-05 | 0.001218 |
102 | REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 8 | 48 | 2.753e-05 | 0.001242 |
103 | CELL MOTILITY | 42 | 835 | 2.802e-05 | 0.001242 |
104 | LOCALIZATION OF CELL | 42 | 835 | 2.802e-05 | 0.001242 |
105 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 48 | 1004 | 2.741e-05 | 0.001242 |
106 | INTRACELLULAR SIGNAL TRANSDUCTION | 67 | 1572 | 2.861e-05 | 0.001256 |
107 | RENAL TUBULE DEVELOPMENT | 10 | 78 | 3.026e-05 | 0.001316 |
108 | REGULATION OF TRANSPORT | 74 | 1804 | 3.763e-05 | 0.001621 |
109 | BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 5 | 16 | 3.798e-05 | 0.001621 |
110 | REGULATION OF HOMEOSTATIC PROCESS | 27 | 447 | 3.983e-05 | 0.001685 |
111 | POSITIVE REGULATION OF ORGAN GROWTH | 7 | 38 | 4.494e-05 | 0.001884 |
112 | REGULATION OF MAPK CASCADE | 35 | 660 | 4.618e-05 | 0.001919 |
113 | KIDNEY MORPHOGENESIS | 10 | 82 | 4.695e-05 | 0.001933 |
114 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 16 | 197 | 5.263e-05 | 0.002111 |
115 | POSITIVE REGULATION OF HEART GROWTH | 6 | 27 | 5.231e-05 | 0.002111 |
116 | AXIS ELONGATION | 6 | 27 | 5.231e-05 | 0.002111 |
117 | NEGATIVE CHEMOTAXIS | 7 | 39 | 5.357e-05 | 0.00213 |
118 | REGULATION OF SYSTEM PROCESS | 29 | 507 | 5.561e-05 | 0.002193 |
119 | SINGLE ORGANISM CELL ADHESION | 27 | 459 | 6.252e-05 | 0.002445 |
120 | REGULATION OF DEVELOPMENTAL GROWTH | 20 | 289 | 6.363e-05 | 0.002446 |
121 | EMBRYO DEVELOPMENT | 43 | 894 | 6.338e-05 | 0.002446 |
122 | REGULATION OF JNK CASCADE | 14 | 159 | 6.414e-05 | 0.002446 |
123 | SECOND MESSENGER MEDIATED SIGNALING | 14 | 160 | 6.867e-05 | 0.002578 |
124 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 11 | 103 | 6.87e-05 | 0.002578 |
125 | INOSITOL PHOSPHATE MEDIATED SIGNALING | 5 | 18 | 7.139e-05 | 0.002658 |
126 | REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 6 | 29 | 8.036e-05 | 0.002968 |
127 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 72 | 1784 | 8.1e-05 | 0.002968 |
128 | REGULATION OF HEART GROWTH | 7 | 42 | 8.791e-05 | 0.003196 |
129 | PATTERN SPECIFICATION PROCESS | 25 | 418 | 8.941e-05 | 0.003225 |
130 | CARDIAC CHAMBER DEVELOPMENT | 13 | 144 | 9.011e-05 | 0.003225 |
131 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 17 | 229 | 9.526e-05 | 0.003333 |
132 | POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 19 | 9.485e-05 | 0.003333 |
133 | POST EMBRYONIC DEVELOPMENT | 10 | 89 | 9.508e-05 | 0.003333 |
134 | SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 30 | 9.828e-05 | 0.003413 |
135 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 58 | 1360 | 0.0001014 | 0.003494 |
136 | DIGESTIVE SYSTEM DEVELOPMENT | 13 | 148 | 0.0001191 | 0.004016 |
137 | MUSCLE CONTRACTION | 17 | 233 | 0.0001176 | 0.004016 |
138 | SKIN DEVELOPMENT | 16 | 211 | 0.0001186 | 0.004016 |
139 | PROSTATE GLANDULAR ACINUS DEVELOPMENT | 4 | 11 | 0.0001232 | 0.004126 |
140 | SKELETAL SYSTEM DEVELOPMENT | 26 | 455 | 0.0001358 | 0.004515 |
141 | SMOOTH MUSCLE CONTRACTION | 7 | 45 | 0.0001384 | 0.004566 |
142 | REGULATION OF ION TRANSPORT | 31 | 592 | 0.0001564 | 0.005125 |
143 | REGULATION OF SYNAPSE ORGANIZATION | 11 | 113 | 0.0001591 | 0.005177 |
144 | NEGATIVE REGULATION OF LOCOMOTION | 18 | 263 | 0.0001678 | 0.005421 |
145 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 13 | 154 | 0.0001775 | 0.005696 |
146 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 75 | 1929 | 0.0001834 | 0.005846 |
147 | REGULATION OF SYNAPSE ASSEMBLY | 9 | 79 | 0.0001901 | 0.006018 |
148 | RESPONSE TO FIBROBLAST GROWTH FACTOR | 11 | 116 | 0.0002008 | 0.006313 |
149 | EPITHELIAL CELL DIFFERENTIATION | 27 | 495 | 0.0002161 | 0.006747 |
150 | SKELETAL SYSTEM MORPHOGENESIS | 15 | 201 | 0.0002285 | 0.007089 |
151 | REGULATION OF MEMBRANE POTENTIAL | 21 | 343 | 0.0002347 | 0.007183 |
152 | MESODERM DEVELOPMENT | 11 | 118 | 0.0002334 | 0.007183 |
153 | POSITIVE REGULATION OF LOCOMOTION | 24 | 420 | 0.0002434 | 0.007404 |
154 | REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 5 | 23 | 0.0002521 | 0.007569 |
155 | NEGATIVE REGULATION OF CELL COMMUNICATION | 51 | 1192 | 0.0002509 | 0.007569 |
156 | CYTOKINE PRODUCTION | 11 | 120 | 0.0002705 | 0.008068 |
157 | SECRETION | 30 | 588 | 0.0003094 | 0.009111 |
158 | NEURAL CREST CELL MIGRATION | 7 | 51 | 0.0003091 | 0.009111 |
159 | EPIDERMIS DEVELOPMENT | 17 | 253 | 0.0003131 | 0.009162 |
160 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 40 | 876 | 0.0003333 | 0.009693 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 43 | 629 | 6.122e-09 | 5.687e-06 |
2 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 26 | 315 | 1.923e-07 | 8.933e-05 |
3 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 60 | 1199 | 5.798e-07 | 0.0001795 |
4 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 25 | 328 | 1.443e-06 | 0.0003351 |
5 | REGULATORY REGION NUCLEIC ACID BINDING | 44 | 818 | 3.365e-06 | 0.0005211 |
6 | SEQUENCE SPECIFIC DNA BINDING | 52 | 1037 | 3.283e-06 | 0.0005211 |
7 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 19 | 226 | 6.539e-06 | 0.0008678 |
8 | ZINC ION BINDING | 54 | 1155 | 1.575e-05 | 0.001829 |
9 | DOUBLE STRANDED DNA BINDING | 40 | 764 | 1.775e-05 | 0.001832 |
10 | RECEPTOR BINDING | 62 | 1476 | 8.846e-05 | 0.008218 |
11 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 14 | 168 | 0.0001161 | 0.00978 |
12 | STEROID HORMONE RECEPTOR ACTIVITY | 8 | 59 | 0.0001263 | 0.00978 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 55 | 1151 | 7.001e-06 | 0.004088 |
2 | SYNAPSE | 39 | 754 | 2.962e-05 | 0.008648 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Calcium_signaling_pathway_hsa04020 | 15 | 182 | 7.586e-05 | 0.003945 | |
2 | Regulation_of_actin_cytoskeleton_hsa04810 | 14 | 208 | 0.001017 | 0.02644 | |
3 | MAPK_signaling_pathway_hsa04010 | 17 | 295 | 0.001727 | 0.02796 | |
4 | Hippo_signaling_pathway_hsa04390 | 11 | 154 | 0.002151 | 0.02796 | |
5 | Ras_signaling_pathway_hsa04014 | 14 | 232 | 0.002822 | 0.02896 | |
6 | cGMP_PKG_signaling_pathway_hsa04022 | 11 | 163 | 0.003342 | 0.02896 | |
7 | Wnt_signaling_pathway_hsa04310 | 10 | 146 | 0.004536 | 0.0337 | |
8 | Apelin_signaling_pathway_hsa04371 | 9 | 137 | 0.009001 | 0.05851 | |
9 | Neuroactive_ligand_receptor_interaction_hsa04080 | 14 | 278 | 0.01319 | 0.07115 | |
10 | cAMP_signaling_pathway_hsa04024 | 11 | 198 | 0.01368 | 0.07115 | |
11 | ABC_transporters_hsa02010 | 4 | 45 | 0.02802 | 0.1324 | |
12 | Hedgehog_signaling_pathway_hsa04340 | 4 | 47 | 0.03223 | 0.1337 | |
13 | Focal_adhesion_hsa04510 | 10 | 199 | 0.03343 | 0.1337 | |
14 | Adherens_junction_hsa04520 | 5 | 72 | 0.03773 | 0.1368 | |
15 | PI3K_Akt_signaling_pathway_hsa04151 | 15 | 352 | 0.03945 | 0.1368 | |
16 | Gap_junction_hsa04540 | 5 | 88 | 0.07631 | 0.2216 | |
17 | Ferroptosis_hsa04216 | 3 | 40 | 0.08292 | 0.2216 | |
18 | Phospholipase_D_signaling_pathway_hsa04072 | 7 | 146 | 0.08307 | 0.2216 | |
19 | Sphingolipid_signaling_pathway_hsa04071 | 6 | 118 | 0.08399 | 0.2216 | |
20 | Rap1_signaling_pathway_hsa04015 | 9 | 206 | 0.08522 | 0.2216 | |
21 | Cellular_senescence_hsa04218 | 7 | 160 | 0.1191 | 0.2949 | |
22 | FoxO_signaling_pathway_hsa04068 | 6 | 132 | 0.1252 | 0.2958 | |
23 | Peroxisome_hsa04146 | 4 | 83 | 0.1651 | 0.3549 | |
24 | Hippo_signaling_pathway_multiple_species_hsa04392 | 2 | 29 | 0.1704 | 0.3549 | |
25 | Cell_adhesion_molecules_.CAMs._hsa04514 | 6 | 145 | 0.1706 | 0.3549 | |
26 | NF_kappa_B_signaling_pathway_hsa04064 | 4 | 95 | 0.2281 | 0.434 | |
27 | Autophagy_animal_hsa04140 | 5 | 128 | 0.2334 | 0.434 | |
28 | Mitophagy_animal_hsa04137 | 3 | 65 | 0.2337 | 0.434 | |
29 | Phosphatidylinositol_signaling_system_hsa04070 | 4 | 99 | 0.2504 | 0.4437 | |
30 | HIF_1_signaling_pathway_hsa04066 | 4 | 100 | 0.256 | 0.4437 | |
31 | Tight_junction_hsa04530 | 6 | 170 | 0.273 | 0.4579 | |
32 | ECM_receptor_interaction_hsa04512 | 3 | 82 | 0.3528 | 0.5611 | |
33 | TGF_beta_signaling_pathway_hsa04350 | 3 | 84 | 0.3668 | 0.5611 | |
34 | ErbB_signaling_pathway_hsa04012 | 3 | 85 | 0.3739 | 0.5611 | |
35 | AMPK_signaling_pathway_hsa04152 | 4 | 121 | 0.3777 | 0.5611 | |
36 | Oocyte_meiosis_hsa04114 | 4 | 124 | 0.3952 | 0.5708 | |
37 | VEGF_signaling_pathway_hsa04370 | 2 | 59 | 0.4501 | 0.6326 | |
38 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 4 | 139 | 0.4809 | 0.6581 | |
39 | p53_signaling_pathway_hsa04115 | 2 | 68 | 0.5247 | 0.6975 | |
40 | Cytokine_cytokine_receptor_interaction_hsa04060 | 7 | 270 | 0.5439 | 0.6975 | |
41 | Phagosome_hsa04145 | 4 | 152 | 0.5511 | 0.6975 | |
42 | Jak_STAT_signaling_pathway_hsa04630 | 4 | 162 | 0.6015 | 0.7024 | |
43 | Necroptosis_hsa04217 | 4 | 164 | 0.6112 | 0.7024 | |
44 | Cell_cycle_hsa04110 | 3 | 124 | 0.6213 | 0.7024 | |
45 | Endocytosis_hsa04144 | 5 | 244 | 0.7548 | 0.8177 | |
46 | Apoptosis_hsa04210 | 2 | 138 | 0.8732 | 0.9267 | |
47 | mTOR_signaling_pathway_hsa04150 | 2 | 151 | 0.9031 | 0.9392 |